Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MSc EBHC, University of Oxford
Award Date: 1 Jan 2015
PhD, Imperial College London
Award Date: 1 Dec 2007
MBBS, University of Melbourne
Award Date: 12 Dec 1995
Collaborations and top research areas from the last five years
Projects
- 2 Active
-
Molecular dissection of allergen sensitisation and immunotherapy: direct application to precision medicine in treatment of asthma
van Zelm, M., O'Hehir, R., Wines, B. & Hew, M.
1/01/21 → 31/12/24
Project: Research
-
Allergic broncho-pulmonary aspergillosis: Old disease, new frontiers
Denton, E., Wark, P. & Hew, M., Aug 2024, In: Respirology. 29, 8, 3 p.Research output: Contribution to journal › Comment / Debate › Other › peer-review
Open Access -
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry
Scelo, G., Torres-Duque, C. A., Maspero, J., Tran, T. N., Murray, R., Martin, N., Menzies-Gow, A. N., Hew, M., Peters, M. J., Gibson, P. G., Christoff, G. C., Popov, T. A., Côté, A., Bergeron, C., Dorscheid, D., FitzGerald, J. M., Chapman, K. R., Boulet, L. P., Bhutani, M., Sadatsafavi, M., & 66 others , Jan 2024, In: Annals of Allergy, Asthma and Immunology. 132, 1, p. 42-53 12 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access11 Citations (Scopus) -
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients
Thomas, D., McDonald, V. M., Stevens, S., Harvey, E. S., Baraket, M., Bardin, P., Bowden, J. J., Bowler, S., Chien, J., Chung, L. P., Gillman, A., Hew, M., Hodge, S., James, A., Jenkins, C., Katelaris, C. H., Katsoulotos, G. P., Langton, D., Lee, J., Marks, G., & 9 others , Feb 2024, In: Allergy. 79, 2, p. 384-392 9 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access16 Citations (Scopus) -
Dupilumab-associated hypereosinophilia in severe asthma
Strong, A., Lin, T., Sverrild, A., Mackay, A., Lee, J., Zubrinich, C., Pham, J., Bosco, J., Denton, E., Dols, M., Stirling, R. G., Dabscheck, E., Iyer, J., Gillman, A. & Hew, M., 1 Jul 2024, In: ERJ Open Research. 10, 4, 4 p., 00048-2024.Research output: Contribution to journal › Letter › Other › peer-review
Open Access -
Expansion of phenotypically modified type 2 memory B cells after allergen immunotherapy
von Borstel, A., Reinwald, S., Aui, P. M., McKenzie, C. I., Varese, N., Hogarth, P. M., Hew, M., O'Hehir, R. E. & van Zelm, M. C., 2024, (Accepted/In press) In: Allergy. 3 p.Research output: Contribution to journal › Letter › Research › peer-review
Open Access2 Citations (Scopus)
Prizes
-
Alfred Health Recognising Excellence Award. Leading Innovation: Difficult Asthma Service
Hew, Mark (Recipient), 2016
Prize: Prize (including medals and awards)
-
Dan Czarny Prize for Research in Allergy & Asthma, Alfred Health
Hew, Mark (Recipient), 2015
Prize: Prize (including medals and awards)
Activities
-
Sanofi-Aventis Australia Pty Ltd (External organisation)
Mark Hew (Member)
2020Activity: Industry, Government and Philanthropy Engagement and Partnerships › Membership of an advisory panel/policy group/ board
-
Genzyme (External organisation)
Mark Hew (Member)
2020Activity: Industry, Government and Philanthropy Engagement and Partnerships › Membership of an advisory panel/policy group/ board
-
Alfred Allergy Course (RACGP-accredited) 2020
Mark Hew (Organiser)
2020Activity: Participating in or organising an event types › Contribution to workshop, seminar, course
-
GlaxoSmithKline Plc (GSK) (New Zealand) (External organisation)
Mark Hew (Member)
2020Activity: Industry, Government and Philanthropy Engagement and Partnerships › Membership of an advisory panel/policy group/ board
-
International Severe Asthma Registry (ISAR) (External organisation)
Mark Hew (Member)
2020Activity: Industry, Government and Philanthropy Engagement and Partnerships › Membership of an advisory panel/policy group/ board